Cannabis Science Inc (OTCMKTS:CBIS) Products will now be available on the shelves of legal dispensaries within the State of California. The official announcement was made by Cannabis Science, Inc; the U.S based patient-oriented biotech company focusing on the development of cannabis-based medicines. Cannabis has been illegal before the law and its use called for hefty penalties or even a jail term. Apparently, the illegality and fear of being jailed have led people to the black market, where they get it at a lower price and tax-free for suppliers.
However, things have changed according to Cannabis Science CEO Raymond C. Dabney. He says that it such a milestone to have what has previously been viewed as an illegal drug find its way into the stores. Of the many dispensaries on schedule to receive the new CBIS product line is MedMen of West Hollywood in Southern California. This will be a plus to its existing CBIS Tincture, the CBIS Healing Balm, and the Solace Drops.
A milestone for legal self-medicating patients
This perhaps is the best news this year for the California patients, who are authorized to self-medicate. Those who are allowed to use cannabis for medicinal and recreational have nothing to fear anymore in regards to being penalized. Being one of the leading dispensaries in Los Angele, MedMen is likely to be the biggest beneficially of the latest move. In fact, the dispensary’s hope is to have more innovative products that will help in driving revenue to the next level. That said Cannabis Science has decided to increase production of its medicinal lines.
Learn about Cannabis Science, Inc.
The pioneering biotech company creates medical cannabinoid formulations that have been built from cannabinoid compounds. The company works hand in hand with drug development experts, clinical research, and personal medical experts. These are the people that give guidance and insights into development manufacturing and the commercialization of the products and therapeutic approaches.
THE MORNING REPORT
Start your workday the right way with the news that matters most.
Your information is 100% secure with us and will never be shared Disclaimer & Privacy Policy
For clinical trials, the company uses materials from GMP-compliant cultivation and production facilities. It utilizes the unique understanding it has in metabolic processes, which result in novel treatment approaches of a wide range of sicknesses. With the legality on board and being that it has the world’s sixth-largest economy CBIS will now shift its focus to the California market.
